## Abstract Androgen‐independent prostate cancers express high levels of Bcl‐2, and this over‐expression of Bcl‐2 protects prostate cancer cells from undergoing apoptosis. Ursolic acid (UA) has demonstrated an anti‐proliferative effect in various tumor types. The aim of this study is to evaluate th
Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer
✍ Scribed by Robert G. Uzzo; Naomi B. Haas; Paul L. Crispen; Vladimir M. Kolenko
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 393 KB
- Volume
- 112
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
New therapeutic strategies are needed to improve treatment outcomes in men with hormone‐refractory prostate cancer. A better understanding of the molecular mechanisms of cell death in response to therapeutic strategies will help avoid ineffective treatment regimens and provide a molecular basis for new therapeutic modalities targeting apoptosis‐resistant forms of prostate cancer. In this review, the authors focused on the established aberrations of apoptosis in hormone‐refractory prostate cancer, and they have described novel treatment strategies to overcome apoptosis resistance. Cancer 2008. © 2008 American Cancer Society.
📜 SIMILAR VOLUMES